+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Lung Stent Market Report and Forecast 2023-2031

  • PDF Icon


  • 140 Pages
  • April 2023
  • Region: Global
  • Expert Market Research
  • ID: 5786941
The global lung stent market size attained a value of about USD 97.47 million in 2022. The market is expected to grow at a CAGR of 6% during the forecast period of 2023-2031 to attain a value of early USD 164.68 million by 2031. The anticipated market growth can be attributed to the rising prevalence of respiratory disorders such as lung cancer, COPD, and asthma.

Lung Stent: Introduction

A lung stent is a medical device used to open up a blocked airway in the lungs. It is a tubular structure made of metal or plastic that is inserted into the airway through a bronchoscope. The stent is designed to keep the airway open and allow air to flow freely into and out of the lungs.

Lung stents are typically used to treat patients with conditions such as lung cancer, chronic obstructive pulmonary disease (COPD), and other respiratory disorders that cause narrowing or blockage of the airways. They may also be used to treat complications from certain medical procedures, such as tracheal intubation or lung transplantation.

There are two main types of lung stents: self-expanding stents and balloon-expandable stents. Self-expanding stents are made of metal and expand on their own after being inserted into the airway. Balloon-expandable stents are made of plastic and require inflation with a balloon after insertion.

Lung stents can provide significant relief to patients with blocked airways, improving their ability to breathe and reducing symptoms such as coughing and shortness of breath. However, they are not without risks, and complications such as stent migration, infection, and tissue damage can occur. Lung stents are typically only used in cases where other treatments have failed, and the benefits outweigh the risks.

Global Lung Stent Market: Application and Uses

Lung stents are medical devices that are used to treat various respiratory disorders by providing support to the airways, preventing them from collapsing or narrowing. Some of the key applications and uses of lung stents include:
  • Lung Cancer: Lung stents are commonly used in the treatment of lung cancer to open up blocked airways and improve breathing. They are often used in combination with other treatments such as chemotherapy and radiation therapy
  • Chronic Obstructive Pulmonary Disease (COPD): COPD is a group of lung diseases that cause breathing difficulties. Lung stents are used to open up narrowed airways in patients with severe COPD, helping to improve breathing and reduce symptoms
  • Bronchial Stenosis: This is a condition in which the airways in the lungs become narrowed or blocked, causing breathing difficulties. Lung stents are used to open up these airways and restore normal breathing
  • Tracheal Stenosis: Tracheal stenosis is a condition in which the windpipe becomes narrowed, making it difficult to breathe. Lung stents can be used to open up the trachea and improve breathing
  • Endobronchial Tumours: Lung stents are used in the treatment of endobronchial tumours, which can block the airways and cause breathing difficulties. The stent is placed to keep the airways open and improve breathing
Lung stents can be made from a variety of materials, including metal, silicone, and biodegradable materials. They are typically placed using minimally invasive techniques such as bronchoscopy, which reduces the risk of complications and allows for a faster recovery time.

Global Lung Stent Market Segmentations

Market segmentation by Type

  • Tracheobronchial Stents
  • Laryngeal Stents

Market segmentation by Material

Metal Stents

  • Nitinol Stents
  • Stainless Steel Stains
  • Others
  • Silicone Stents
  • Hybrid Stents

Market segmentation by Product

  • Self-Expandable Stents
  • Non-Expandable Stents

Market segmentation by End User

  • Hospitals
  • Ambulatory Surgery Centres
  • Others

Global Lung Stent Market Breakup by Region

North America

  • United States of America
  • Canada


  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Global Lung Stent Market Scenario

The global lung stent market is expected to experience significant growth over the next few years. The market is being driven by several factors, including:
  • Increasing prevalence of respiratory disorders such as lung cancer, COPD, and asthma
  • Advancements in technology and materials used in lung stent manufacturing, which has led to the development of more efficient and biocompatible stents
  • Growing demand for minimally invasive procedures that can be performed on an outpatient basis, reducing hospital stays and overall healthcare costs
  • Rising adoption of lung stents in emerging markets such as China and India, due to increasing healthcare expenditure and improving healthcare infrastructure
However, the market growth is being hampered by several factors such as high cost associated with lung stent treatment, lack of awareness about the availability of these treatments, and the potential risk of complications associated with their use.

Geographically, North America and Europe are the largest markets for lung stents, due to the high prevalence of respiratory disorders in these regions and the availability of advanced healthcare infrastructure. The Asia-Pacific region is expected to experience the highest growth rate due to the increasing patient population and improving healthcare infrastructure in countries such as China and India.

Key Players in the Global Lung Stent Market

The report gives an in-depth analysis of the key players involved in the global lung stent market. The companies included in the market are as follows:
  • Boston Scientific Corporation
  • Taewoong Medical Co., Ltd
  • Micro-Tech (Nanjing) Co., Ltd
  • Bess Medizintechnik Gmbh
  • E. Benson Hood Laboratories, Inc
  • Merit Medical Systems, Inc
  • Cook Group Incorporated
  • Boston Medical Products, Inc
  • Novatech SA
  • Standard Sci. Tech Inc
  • Stening SRL
  • Micro-Tech

This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Lung Stent Market Overview
3.1 Global Lung Stent Market Historical Value (2016-2022)
3.2 Global Lung Stent Market Forecast Value (2023-2031)
4 Global Lung Stent Market Landscape
4.1 Global Lung Stent Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Lung Stent Product Landscape
4.2.1 Analysis by Type of Biosensor
4.2.2 Analysis by Technology Used
4.2.3 Analysis by Applications
5 Global Lung Stent Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Lung Stent Market Segmentation
6.1 Global Lung Stent Market by Type
6.1.1 Market Overview
6.1.2 Tracheobronchial Stents
6.1.3 Laryngeal Stents
6.2 Global Lung Stent Market by Material
6.2.1 Market Overview
6.2.2 Metal Stents Nitinol Stents Stainless Steel Stains Others
6.2.3 Silicone Stents
6.2.4 Hybrid Stents
6.3 Global Lung Stent Market by Product
6.3.1 Market Overview
6.3.2 Self-Expandable Stents
6.3.3 Non-Expandable Stents
6.4 Global Lung Stent Market by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Ambulatory Surgery Centres
6.4.4 Others
6.5 Global Lung Stent Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Lung Stent Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Lung Stent Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Lung Stent Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.6 Australia
9.7 Others
10 Latin America Lung Stent Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Lung Stent Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.5 Others
17 Supplier Landscape
17.1 Boston Scientific Corporation
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Taewoong Medical Co., Ltd.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Micro-Tech (Nanjing) Co., Ltd.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Bess Medizintechnik Gmbh
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 E. Benson Hood Laboratories, Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Merit Medical Systems, Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Cook Group Incorporated
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Boston Medical Products, Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Novatech SA
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Standard Sci. Tech Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Stening SRL
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 ENDO-FLEX GmbH
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Micro-Tech
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
18 Global Lung Stent Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Boston Scientific Corporation
  • Taewoong Medical Co. Ltd.
  • Micro-Tech (Nanjing) Co. Ltd.
  • Bess Medizintechnik GmbH
  • E. Benson Hood Laboratories, Inc.
  • Merit Medical Systems, Inc.
  • Cook Group Incorporated
  • Boston Medical Products, Inc.
  • Novatech Sa
  • Standard Sci. Tech Inc.
  • Stening Srl
  • Endo-Flex GmbH
  • Micro-Tech



Table Information